Cargando…

One-year eye-to-eye comparison of wavefront-guided versus wavefront-optimized laser in situ keratomileusis in hyperopes

BACKGROUND: To compare wavefront (WF)-guided and WF-optimized laser in situ keratomileusis (LASIK) in hyperopes with respect to the parameters of safety, efficacy, predictability, refractive error, uncorrected distance visual acuity, corrected distance visual acuity, contrast sensitivity, and higher...

Descripción completa

Detalles Bibliográficos
Autores principales: Sáles, Christopher S, Manche, Edward E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4235493/
https://www.ncbi.nlm.nih.gov/pubmed/25419115
http://dx.doi.org/10.2147/OPTH.S70145
_version_ 1782345036717883392
author Sáles, Christopher S
Manche, Edward E
author_facet Sáles, Christopher S
Manche, Edward E
author_sort Sáles, Christopher S
collection PubMed
description BACKGROUND: To compare wavefront (WF)-guided and WF-optimized laser in situ keratomileusis (LASIK) in hyperopes with respect to the parameters of safety, efficacy, predictability, refractive error, uncorrected distance visual acuity, corrected distance visual acuity, contrast sensitivity, and higher order aberrations. METHODS: Twenty-two eyes of eleven participants with hyperopia with or without astigmatism were prospectively randomized to receive WF-guided LASIK with the VISX CustomVue S4 IR or WF-optimized LASIK with the WaveLight Allegretto Eye-Q 400 Hz. LASIK flaps were created using the 150-kHz IntraLase iFS. Evaluations included measurement of uncorrected distance visual acuity, corrected distance visual acuity, <5% and <25% contrast sensitivity, and WF aberrometry. Patients also completed a questionnaire detailing symptoms on a quantitative grading scale. RESULTS: There were no statistically significant differences between the groups for any of the variables studied after 12 months of follow-up (all P>0.05). CONCLUSION: This comparative case series of 11 subjects with hyperopia showed that WF-guided and WF-optimized LASIK had similar clinical outcomes at 12 months.
format Online
Article
Text
id pubmed-4235493
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-42354932014-11-21 One-year eye-to-eye comparison of wavefront-guided versus wavefront-optimized laser in situ keratomileusis in hyperopes Sáles, Christopher S Manche, Edward E Clin Ophthalmol Original Research BACKGROUND: To compare wavefront (WF)-guided and WF-optimized laser in situ keratomileusis (LASIK) in hyperopes with respect to the parameters of safety, efficacy, predictability, refractive error, uncorrected distance visual acuity, corrected distance visual acuity, contrast sensitivity, and higher order aberrations. METHODS: Twenty-two eyes of eleven participants with hyperopia with or without astigmatism were prospectively randomized to receive WF-guided LASIK with the VISX CustomVue S4 IR or WF-optimized LASIK with the WaveLight Allegretto Eye-Q 400 Hz. LASIK flaps were created using the 150-kHz IntraLase iFS. Evaluations included measurement of uncorrected distance visual acuity, corrected distance visual acuity, <5% and <25% contrast sensitivity, and WF aberrometry. Patients also completed a questionnaire detailing symptoms on a quantitative grading scale. RESULTS: There were no statistically significant differences between the groups for any of the variables studied after 12 months of follow-up (all P>0.05). CONCLUSION: This comparative case series of 11 subjects with hyperopia showed that WF-guided and WF-optimized LASIK had similar clinical outcomes at 12 months. Dove Medical Press 2014-11-12 /pmc/articles/PMC4235493/ /pubmed/25419115 http://dx.doi.org/10.2147/OPTH.S70145 Text en © 2014 Sáles and Manche. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Sáles, Christopher S
Manche, Edward E
One-year eye-to-eye comparison of wavefront-guided versus wavefront-optimized laser in situ keratomileusis in hyperopes
title One-year eye-to-eye comparison of wavefront-guided versus wavefront-optimized laser in situ keratomileusis in hyperopes
title_full One-year eye-to-eye comparison of wavefront-guided versus wavefront-optimized laser in situ keratomileusis in hyperopes
title_fullStr One-year eye-to-eye comparison of wavefront-guided versus wavefront-optimized laser in situ keratomileusis in hyperopes
title_full_unstemmed One-year eye-to-eye comparison of wavefront-guided versus wavefront-optimized laser in situ keratomileusis in hyperopes
title_short One-year eye-to-eye comparison of wavefront-guided versus wavefront-optimized laser in situ keratomileusis in hyperopes
title_sort one-year eye-to-eye comparison of wavefront-guided versus wavefront-optimized laser in situ keratomileusis in hyperopes
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4235493/
https://www.ncbi.nlm.nih.gov/pubmed/25419115
http://dx.doi.org/10.2147/OPTH.S70145
work_keys_str_mv AT saleschristophers oneyeareyetoeyecomparisonofwavefrontguidedversuswavefrontoptimizedlaserinsitukeratomileusisinhyperopes
AT mancheedwarde oneyeareyetoeyecomparisonofwavefrontguidedversuswavefrontoptimizedlaserinsitukeratomileusisinhyperopes